
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TSPAN7 CRISPR/Cas9 KO Plasmid (m) | sc-423425 | 20 µg | $397.00 |
Tspan7 encodes the tetraspanin protein TSPAN7, a multi-pass membrane scaffold that organizes tetraspanin-enriched microdomains and modulates the distribution and signaling of partner receptors at the cell surface. In mouse, TSPAN7 is implicated in membrane trafficking, cytoskeletal remodeling, and cell–cell communication processes that influence neuronal development and synaptic organization, and it can also affect adhesion and motility programs in other cell types. Through interactions that shape receptor clustering and downstream signaling, TSPAN7 contributes to pathways linked to endocytosis, actin dynamics, and signal transduction at specialized membrane compartments. Dysregulated tetraspanin network function has been associated with neurodevelopmental phenotypes and altered cellular connectivity, making Tspan7 a useful locus for mechanistic studies of membrane microdomain biology.
TSPAN7 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tspan7 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tspan7 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tspan7 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TSPAN7 protein expression.
This CRISPR knockout system enables efficient generation of Tspan7-deficient cell models for investigation of TSPAN7 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.